VivoSim Labs Return on Equity (ROE) Growth & History (VIVS)
VivoSim Labs's return on equity was −294.75% for fiscal 2026.
View full VivoSim Labs company overviewVivoSim Labs annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −294.75% | −259.44 pp |
| 2025 | 2025-03-31 | −35.31% | +119.69 pp |
| 2024 | 2024-03-31 | −155.00% | −79.20 pp |
| 2023 | 2023-03-31 | −75.80% | −42.81 pp |
| 2022 | 2022-03-31 | −32.99% | +18.13 pp |
| 2021 | 2021-03-31 | −51.12% | +8.34 pp |
| 2020 | 2020-03-31 | −59.46% | +6.40 pp |
| 2019 | 2019-03-31 | −65.86% | −0.78 pp |
| 2018 | 2018-03-31 | −65.08% | −3.34 pp |
| 2017 | 2017-03-31 | −61.74% | +7.84 pp |
| 2016 | 2016-03-31 | −69.58% | −7.54 pp |
| 2015 | 2015-03-31 | −62.04% | +28.26 pp |
| 2014 | 2014-03-31 | −90.29% | +789.14 pp |
| 2013 | 2013-03-31 | −879.43% | — |
VivoSim Labs quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2026 | 2026-03-31 | −344.94% | −471.18 pp |
| Q3 2026 | 2025-12-31 | −46.78% | +123.70 pp |
| Q2 2026 | 2025-09-30 | −30.66% | +18.64 pp |
| Q1 2026 | 2025-06-30 | −28.39% | +36.78 pp |
| Q4 2025 | 2025-03-31 | 126.23% | +188.49 pp |
| Q3 2025 | 2024-12-31 | −170.47% | −121.23 pp |
| Q2 2025 | 2024-09-30 | −49.29% | −9.81 pp |
| Q1 2025 | 2024-06-30 | −65.17% | −35.44 pp |
| Q4 2024 | 2024-03-31 | −62.25% | −22.59 pp |
| Q3 2024 | 2023-12-31 | −49.24% | −35.44 pp |
| Q2 2024 | 2023-09-30 | −39.48% | −26.87 pp |
| Q1 2024 | 2023-06-30 | −29.72% | −18.61 pp |
| Q4 2023 | 2023-03-31 | −39.66% | — |
| Q3 2023 | 2022-12-31 | −13.80% | −3.12 pp |
| Q2 2023 | 2022-09-30 | −12.61% | −2.81 pp |
| Q1 2023 | 2022-06-30 | −11.11% | −4.50 pp |
| Q3 2022 | 2021-12-31 | −10.69% | +1.64 pp |
| Q2 2022 | 2021-09-30 | −9.80% | +30.18 pp |
| Q1 2022 · Jun 30 | 2021-06-30 | −6.62% | +4.15 pp |
| Q4 2021 | 2021-03-31 | −8.66% | +1.14 pp |
| Q3 2021 | 2020-12-31 | −12.33% | −1.10 pp |
| Q2 2021 | 2020-09-30 | −39.98% | −21.25 pp |
| Q1 2021 | 2020-06-30 | −10.77% | +6.69 pp |
| Q4 2020 | 2020-03-31 | −9.80% | +9.61 pp |
| Q3 2020 | 2019-12-31 | −11.23% | +5.94 pp |
| Q2 2020 | 2019-09-30 | −18.73% | −4.18 pp |
| Q1 2020 | 2019-06-30 | −17.46% | −0.20 pp |
| Q4 2019 | 2019-03-31 | −19.40% | −3.42 pp |
| Q3 2019 | 2018-12-31 | −17.17% | −1.69 pp |
| Q2 2019 | 2018-09-30 | −14.55% | +2.76 pp |
| Q1 2019 | 2018-06-30 | −17.26% | −0.37 pp |
| Q4 2018 | 2018-03-31 | −15.99% | +0.01 pp |
| Q3 2018 | 2017-12-31 | −15.48% | +0.05 pp |
| Q2 2018 | 2017-09-30 | −17.31% | +0.29 pp |
| Q1 2018 | 2017-06-30 | −16.89% | −1.91 pp |
| Q4 2017 | 2017-03-31 | −15.99% | −3.23 pp |
| Q3 2017 | 2016-12-31 | −15.53% | −1.13 pp |
| Q2 2017 | 2016-09-30 | −17.59% | −3.65 pp |
| Q1 2017 | 2016-06-30 | −14.98% | −2.31 pp |
| Q4 2016 | 2016-03-31 | −12.76% | +3.32 pp |
| Q3 2016 | 2015-12-31 | −14.40% | −0.65 pp |
| Q2 2016 | 2015-09-30 | −13.94% | +4.27 pp |
| Q1 2016 | 2015-06-30 | −12.67% | +1.30 pp |
| Q4 2015 | 2015-03-31 | −16.08% | −2.71 pp |
| Q3 2015 | 2014-12-31 | −13.75% | −3.40 pp |
| Q2 2015 | 2014-09-30 | −18.22% | +17.08 pp |
| Q1 2015 | 2014-06-30 | −13.97% | +33.53 pp |
| Q4 2014 | 2014-03-31 | −13.37% | +866.06 pp |
| Q3 2014 | 2013-12-31 | −10.35% | — |
| Q2 2014 | 2013-09-30 | −35.30% | — |
| Q1 2014 | 2013-06-30 | −47.50% | — |
| Q4 2013 | 2013-03-31 | −879.43% | — |
VivoSim Labs return on equity trends
Over the last five fiscal years, VivoSim Labs's return on equity decreased from −51.12% to −294.75%, a change of −243.63 percentage points. The latest reported quarter, Q4 2026, shows −344.94%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review VivoSim Labs source filings ↗